Anahita ("Ana") Anvari is a member of DLA Piper's Healthcare Industry team. Ana represents clients in the healthcare industry through a wide range of regulatory, compliance, and transactional matters, including mergers & acquisitions and corporate governance. She advises clients on regulatory compliance under federal and state law, including compensation structures, corporate practice of medicine, licensure, scope of practice, fraud and abuse, HIPAA and Part 2. Ana regularly counsels on healthcare regulatory issues for complex transactions, including managing due diligence.
Ana’s practice experience features a variety of clients including private equity firms, healthcare systems, hospitals, ambulatory surgery centers, health care technology groups, physician groups, medical spas, and other healthcare companies. Ana's experience includes managing and advising pharmacies in licensure processes and on controlled substance laws.
Prior to joining DLA Piper, Ana worked as an associate in the healthcare practice group of AM Law 100 law firms in Los Angeles and Philadelphia. In law school, Ana served as an Editor of the Penn State, Dickinson Law Review, a Fellow of the Philadelphia Diversity Law Group, and is a member of the Woolsack Honor Society.
DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA piper's structure, please refer the Legal Notices page of this website. All rights reserved. Attorney advertising.
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.